Because OPN expression is markedly elevated in the micromilieu of several chronic inflammatory conditions such as RA and cancer (14, 55) and genetic deficiency or blockade of OPN ameliorates the development of these diseases (17, 18), OPN may be of interest as a fruitful target for various diseases. This evidence concerns the gene SPP1 and rheumatoid arthritis.